Call: 631.543.3334

Gemini Pharmaceuticals Inc. Expands Sales Team

For Immediate Release

brianCommack, NY, March 7, 2016 – Gemini Pharmaceuticals Inc., a global manufacturer of science based dietary and nutritional supplements for the past 33 years, announces the addition of Brian Lamb to its sales team. In his new role, he will be Sr. Director of Strategic sales.

Brian has over 25 years of sales and marketing experience with more than 15 years concentrating on private brand dietary supplements. He was previously with Natural Alternatives International as Director of Business Development, and before that with Arizona Nutritional Supplements. During his career, Brian has worked with just about every major dietary supplement brand owner in the US.

“Working with Gemini is an exciting new opportunity for me. They have developed a solid reputation in the industry for producing the highest quality dietary supplements while helping ensure their client’s cGMP compliance” commented Brian.

“We are very excited to have Brian as a member of our Gemini sales team. His primary focus will be to expand our product distribution in the brand owner/ own label distributor segment of the dietary supplement industry. In addition, he will help develop the processes and recommend the staff needed to accommodate significant expansion of Gemini business in this market segment. Brian has established close relationships with many brand owners which resulted in significant growth for his former companies. His many years of experience will be a great asset to Gemini as we are committed to aggressively exceed our consistent year-over-year double-digit growth” offers Mike Finamore, CEO of Gemini Pharmaceuticals Inc.

About Gemini Pharmaceuticals Inc.:

Gemini Pharmaceuticals Inc. is a global manufacturer of science based dietary and nutritional supplements. With over 30 years of experience, Gemini has grown to be a world class manufacturer of solid dosage product with production exceeding 13 billion tablets / capsules per year. The quality of the operation has been recognized by the achievement of both NSF and TGA registrations and the issuance of a Foreign Site Reference Number by Health Canada. Gemini also produces its products in compliance with both Kosher and Halal requirements. For additional information about Gemini Pharmaceuticals please see www.geminipharm.com or contact Mark Jost at mjost@geminipharm.com

Media Contact: Mark Jost, 631-543-3334; mjost@geminipharm.com

Comments are closed.